- Drugs
- Tuesday, 07 Jan 2020
Harvest Files Suit Against Falcon International, Inc.
Harvest Health & Recreation Inc. (CSE: HARV, OTCQX: HRVSF) ("Harvest"), a vertically integrated cannabis company with one of the largest and deepest footprints in the U.S., announced that yesterday Harvest filed suit against Falcon International, Inc. ("Falcon") requesting termination and rescission of the Merger Agreement ("Transaction") and return of money Harvest paid to Falcon under the Merger Agreement. As detailed in the Complaint, filed in U.S. Federal Court, District of Arizona, Harvest alleges that Falcon has failed to meet its legal obligations in multiple ways, including the failure to provide auditable financial records, which precludes Harvest from moving forward with the Transaction.
While Harvest remains committed to the long-term potential of legal cannabis sales in California, current market conditions make it difficult to operate profitably there today. If the Transaction does not close for any reason, including those enumerated in the Complaint, the company plans to remove the contribution attributable to Falcon from its 2020 pro forma guidance. Harvest expects overall 2020 pro forma profitability would improve without the revenue contribution from Falcon.
Related Industry Updates
North America Radiopharmaceutical Theragnostic Market is expected to reach US$ 1,529.88 million by 2028
Mar 13, 2023
Mediterranean Fish Vaccine Market is expected to reach US$ 2,09,030.80 million by 2030
Aug 10, 2023
Generic Oncology Drugs Market Size to Grow with Stupendous CAGR of 6.3% from Forecasts 2019 – 2027 | Zydus Cadila, Glenmark, Aurobindo Pharma
Feb 11, 2021
Europe Small Molecule Drug Delivery Market: Industry Overview, Trends and Growth Opportunities Forecasted Till 2027
Aug 25, 2020
Former Deputy Head of China's Drug Regulator Sentenced to 16 Years in Prison
Nov 15, 2019
Shorla Pharma Closes $8.3M Series A Funding Round
Jun 03, 2020
AIkido Pharma Adds Artificial Intelligence Leader to Advisory Board
Mar 23, 2020